Molly Ryan
Pediatrics Residency · New York Presbyterian Hospital
Credentials: ·
History
Research
Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells
Transplantation and Cellular Therapy · 2021 · First of 9 authors · 7 citations
Transplantation and Cellular Therapy · 2026 · First of 6 authors · Corresponding
1 paper
1 paper
1 paper
1 paper
- TB
1 paper